YKL-40 as marker of severe lung disease in cystic fibrosis patients.

Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

YKL-40 as marker of severe lung disease in cystic fibrosis patients.

Resource Type

CF Research News

Authors

Leonardi S

Parisi GF

Capizzi A

Manti S

Cuppari C

Scuderi MG

Rotolo N

Lanzafame A

Musumeci M

Salpietro C

References

J Cyst Fibros. 2016 Jan 8. pii: S1569-1993(15)00315-X.

Document

CF Research News article [1]

Link

Scientific abstract [2]

Theme

Immunology [3]

Keywords

Acute pulmonary exacerbation [4]

Lung function decline [5]

Pulmonary pseudomonas infection [6]

YKL-40 [7]

Date

Friday, January 8, 2016

Featured resource article

Yes

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/ykl-40-marker-severe-lung-disease-cystic-fibrosis-patients

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-15-00337R1_FINAL_Leonardi_21042016.pdf [2] http://www.ncbi.nlm.nih.gov/pubmed/26778616 [3] https://www.ecfs.eu/research-article-themes/immunology [4] https://www.ecfs.eu/research-article-keywords/acute-pulmonary-exacerbation [5] https://www.ecfs.eu/research-article-keywords/lung-function-decline [6] https://www.ecfs.eu/research-article-keywords/pulmonary-pseudomonas-infection [7] https://www.ecfs.eu/research-article-keywords/ykl-40